Search results

Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered

ADMA Biologics ADMA is a U.S.-based commercial-stage biopharmaceutical company focused on developing, manufacturing and marketing specialty biologics for immunodeficient patients and individuals at

KLA KLAC shares dropped 9.3% in the past month, underperforming the broader Zacks Computer and Technology sector’s return of 1.4%. The underperformance can be attributed to investor concerns around

JetBlue Airways Corporation JBLU shares have gained 22.2% in the past three months, putting the durability of the rebound in focus. Better revenue trends and firmer earnings-estimate revisions have

T. Rowe Price Group TROW has benefited from a steady expansion in its diversified asset base despite continued client outflows. Over the past five years (2020-2025), the company’s assets under

Vulcan Materials Company VMC continues to improve aggregates unit economics. Second-quarter pricing rose, cash gross profit per ton increased and public infrastructure plus large private projects

Verizon Communications Inc. VZ is positioning its fiber network and existing infrastructure for the growing demand for AI connectivity. The company recently signed a more than $1 billion agreement

Investors in Lockheed Martin Corporation LMT need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 18, 2026 $330 Call had some of the

Lamar Advertising Company LAMR has entered the second half of 2026 with firmer operating momentum, higher cash generation and an improved full-year outlook. Second-quarter results exceeded